XI. 3. Solar and UV Exposure – Sunlight as a Microbial and Metabolic Regulator

Sunlight is more than warmth: through UV exposure and vitamin D, it tunes your circadian rhythm and immune system, and with them your gut ecosystem.

The rediscovery of these mechanisms, now reframed through the lens of the gut microbiome, the VDR^[G]–immune axis, and circadian biology, suggests that Finsen’s empirical insight was pointing toward a biological system of far greater complexity than he imagined. Solar exposure is not merely a source of warmth or visible light. It is a systemic metabolic regulator – and as the evidence reviewed in this section demonstrates, its influence extends to the gut ecosystem in ways that are only beginning to be understood.

The story of heliotherapy did not end with Finsen. In the early twentieth century, before the era of antibiotics, sanatoria across Switzerland, Scandinavia, and the United States routinely exposed tuberculosis patients to sunlight as part of their treatment protocol. The patients who spent the most time in sunlight fared better – a clinical observation that was empirically sound but mechanistically opaque to its practitioners.

What Finsen could not have known – but what modern science has since established – is that the mechanisms behind his success were almost certainly far more complex than direct UV killing of Mycobacterium tuberculosis on the skin surface. Ultraviolet B radiation triggers the cutaneous synthesis of vitamin D3, which is converted in the liver and kidney to its active hormonal form, 1,25-dihydroxyvitamin D3. This metabolite binds to the vitamin D receptor (VDR) expressed on immune cells, including macrophages, and directly upregulates the transcription of cathelicidin – an endogenous antimicrobial peptide that is among the body’s primary defences against mycobacterial infection.

Historical Perspective: Light as Medicine – Niels Finsen and the Birth of Phototherapy

Solar and UV Exposure – How Light Shapes the Gut Ecosystem

Sunlight is not merely a source of warmth or vitamin D. It is a circadian signal, an immune calibrator, and an indirect but measurable regulator of the gut microbial ecosystem. Its absence – or excess without adaptation – has consequences that extend well beyond skin deep [278], [279].

The most established pathway connecting sunlight to gut health runs through vitamin D. When ultraviolet B (UVB) radiation – wavelengths of 290–315 nm – reaches the skin, it photochemically converts 7-dehydrocholesterol to previtamin D3, which is then thermally isomerized to vitamin D3 (cholecalciferol). After hepatic hydroxylation to 25-hydroxyvitamin D and renal activation to 1,25-dihydroxyvitamin D (calcitriol), the active form reaches the gut via the bloodstream and acts on epithelial and immune cells through the vitamin D receptor (VDR) [278]. Crucially, VDR is expressed not only in intestinal epithelial cells but also in Paneth cells, dendritic cells, macrophages, and T cells throughout the lamina propria (connective tissue layer beneath the intestinal epithelium) (the connective tissue layer beneath the intestinal epithelium) – all key regulators of mucosal immune tone and microbial selection.

Vitamin D signalling through intestinal VDR shapes the microbial environment in multiple ways. VDR activation upregulates the expression of antimicrobial peptides, particularly defensins (α-defensin HD-5 and HD-6), which are secreted by Paneth cells at the base of the intestinal crypts. These defensins exert selective antimicrobial pressure: they suppress opportunistic gram-negative pathogens more potently than they affect gram-positive commensal anaerobes. This selectivity means that vitamin D sufficiency effectively maintains a compositional bias toward commensal species [279], [280]. Conversely, VDR deficiency in mice leads to a dramatically altered gut microbiome: reduced representation of Lactobacillus species, decreased Bifidobacterium abundance, increased proportions of opportunistic Clostridiales, and reduced overall alpha-diversity^[G] [280]. These animal model findings are corroborated by epidemiological data showing that populations with higher circulating 25(OH)D levels consistently demonstrate higher gut microbial richness and lower inflammatory marker profiles [281].

A second major pathway connects sunlight to the gut through circadian rhythm entrainment. The master circadian clock, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, is primarily entrained by light received by retinal ganglion cells. This central clock synchronizes peripheral clocks throughout the body – including in intestinal epithelial cells and within the gut microbiome itself. The microbiome undergoes robust diurnal oscillations in both composition and metabolic activity, cycling predictably over 24 hours in synchrony with host feeding, fasting, and hormonal rhythms [59]. These oscillations are disrupted by inadequate or poorly timed light exposure. Studies of shift workers and jetlagged travellers – groups with chronic circadian misalignment – consistently show altered gut microbiome composition, reduced SCFA production, and increased intestinal permeability^[G] compared to circadian-aligned controls [59], [282]. Conversely, morning bright light exposure, by reinforcing circadian entrainment, supports the regular oscillatory pattern of the gut microbiota and the gut-derived metabolite cycles that regulate appetite, insulin sensitivity, and mucosal immunity.

Beyond vitamin D and circadian regulation, UVB exposure triggers the cutaneous release of nitric oxide (NO) from skin reservoirs, independent of vitamin D synthesis. Nitric oxide acts as a vasodilator and signalling molecule, influencing blood flow to the gut, modulating intestinal motility, and exerting direct antimicrobial effects on certain pathogens in the gut lumen. Though the direct gut microbiome effects of skin-derived NO are less well characterized than those of vitamin D, epidemiological patterns – including the latitude-dependent gradients in inflammatory bowel disease (Inflammatory Bowel Disease: Crohn's disease and ulcerative colitis) prevalence and the strong seasonal correlation of IBD (inflammatory bowel disease: Crohn's disease and ulcerative colitis) flares with low UV index months – suggest that the UVB–NO pathway may contribute independently to gut mucosal stability [283].

The skin microbiome is also directly affected by solar UV exposure. UV radiation alters the composition of the skin microbial community by suppressing UV-sensitive species and enriching UV-resistant ones. Staphylococcus epidermidis, a dominant commensal, produces a UV-absorbing carotenoid pigment that confers partial UV protection to the skin surface. Repeated, intense UV exposure can reduce Staphylococcus epidermidis density and shift the skin toward less diverse communities dominated by UV-tolerant taxa [284]. While the skin microbiome is not the gut microbiome, it communicates with systemic immunity and represents a component of total microbial exposure – particularly relevant in the context of sunscreen overuse, which, while protective against carcinogenesis, may also reduce cutaneous microbial diversity and limit vitamin D synthesis when used at SPF 30+ across all exposed skin without timed, moderate unprotected exposure.

Seasonal variation in gut microbiome composition correlates strongly with UV index changes throughout the year, consistent with vitamin D as a mediating variable. Studies in high-latitude populations – including circumpolar communities with extreme seasonal variation in UV availability – document recurring winter dysbiosis^[G] patterns characterized by reduced Bifidobacterium, reduced SCFA-producing Faecalibacterium prausnitzii^[G], and increased inflammatory taxon abundances, which partially recover during summer months with increasing UV exposure and rising serum 25(OH)D levels [281], [285]. This seasonal microbiome rhythm is not merely a curiosity – it correlates with seasonal patterns of mood, immunity, and metabolic parameters including insulin resistance.

The practical implication is neither heliotherapy nor solar avoidance, but calibrated, regular, moderate UV exposure combined with vitamin D monitoring and – where indicated – supplementation. The specific dose of sun exposure required for adequate vitamin D synthesis varies substantially by latitude, season, skin phototype, and time of day, but a general evidence-based guideline for most adults at temperate latitudes in summer is 15–25 minutes of direct sun exposure to face, arms, and legs (without sunscreen on those areas) around solar noon, three to four times per week. In winter at latitudes above 50°N, UVB irradiance is insufficient for cutaneous vitamin D synthesis on most days regardless of sun exposure duration, making dietary sources and supplementation the primary vitamin D strategy during those months [278], [279].

How to Optimize Sunlight Exposure for Microbiota and Metabolic Health

Seek morning sunlight within 30–60 minutes of waking when possible, even on overcast days – the blue-light component of morning sky penetrates cloud cover sufficiently to support circadian entrainment, even when UVB irradiance is inadequate for vitamin D synthesis. The circadian benefit of morning outdoor light is independent of UV and operates through retinal photoreceptors, not skin.

Allocate a regular period of moderate midday sun exposure to arms, legs, and face on fair-weather days during months when your latitude and season permit UVB synthesis. Use this window without sunscreen on the target skin areas for the minimum duration appropriate for your skin phototype (typically 10–25 minutes), then apply sun protection for extended outdoor time. This approach simultaneously supports vitamin D synthesis and limits carcinogenic UV accumulation.

Monitor serum 25-hydroxyvitamin D levels annually or biannually, particularly if you live above 45°N latitude, work predominantly indoors, have darker skin phototypes that require longer UV exposure for equivalent synthesis, wear concealing clothing for cultural or religious reasons, or have chronic gastrointestinal conditions that impair fat-soluble vitamin absorption. Discuss your result and supplementation need with your physician; the evidence-based sufficiency threshold is generally 50–75 nmol/L (20–30 ng/mL), though optimal levels for gut immune function may be higher.

Protect circadian integrity by avoiding bright artificial light – particularly blue-spectrum light from screens and LED overhead lighting – in the two to three hours before sleep. The circadian clock that regulates gut microbiome oscillations is disrupted by evening light exposure as much as it is supported by morning light exposure. The symmetry matters: morning light exposure and evening light reduction are equally important for maintaining microbial circadian rhythmicity.

In high-latitude winters (above approximately 50°N from October to March), recognize that outdoor UV exposure is unlikely to provide meaningful vitamin D synthesis regardless of duration. During these months, dietary sources – including oily fish, egg yolks, fortified dairy products, and sun-dried mushrooms – provide modest amounts, and supplementation (typically 1,000–2,000 IU vitamin D3 daily for most adults) is widely recommended and supported by evidence. Discuss dosing with your physician, particularly if you have conditions affecting vitamin D metabolism.

Avoid the two extremes that dominate popular discourse around sun and skin health: total solar avoidance (which eliminates vitamin D synthesis, circadian light entrainment benefits, and NO release) and unprotected prolonged sun exposure (which accumulates carcinogenic UV load and causes inflammatory skin damage). The evidence base supports a middle path: regular, moderate, timed exposure.

Microbiota Effects

• Vitamin D receptor (VDR) signalling in intestinal Paneth cells upregulates the expression of α-defensins (HD-5 and HD-6), which exert selective antimicrobial pressure favouring gram-positive commensal anaerobes over gram-negative opportunists; VDR-knockout mouse models demonstrate markedly reduced alpha-diversity, depleted Lactobacillus and Bifidobacterium abundance, and elevated proportions of dysbiotic Clostridiales compared to wild-type controls [279], [280].
• Circulating 25-hydroxyvitamin D levels in observational human cohorts correlate positively with gut microbial alpha-diversity (richness and evenness) and negatively with inflammatory taxon abundance, with the strongest associations documented for Faecalibacterium prausnitzii – a key butyrogenic anti-inflammatory commensal – and Akkermansia muciniphila, an intestinal barrier-supporting mucin-degrader [281].
• The gut microbiome undergoes robust, predictable 24-hour oscillations in composition and metabolic output that are entrained by host circadian rhythms; circadian misalignment caused by irregular light exposure suppresses these oscillations, reduces diurnal SCFA cycling, and increases intestinal permeability – effects that are partially reversed by restoring consistent light–dark cycle exposure [59], [282].
• Seasonal gut microbiome surveys in high-latitude populations document recurring winter reductions in Bifidobacterium spp., Faecalibacterium prausnitzii, and Akkermansia muciniphila, and increases in inflammatory Proteobacteria proportions, temporally correlated with declining UV index and serum 25(OH)D levels; partial recovery during summer months parallels UV index increases [281], [285].
• VDR signalling modulates intestinal tight junction^[G] protein expression (occludin, claudin-1, ZO-1), supporting epithelial barrier integrity; vitamin D insufficiency in human cohorts is associated with increased serum markers of gut permeability (zonulin^[G], lipopolysaccharide-binding protein), independent of inflammatory bowel disease diagnosis [279], [280].
• Skin microbiome composition is modified by UV exposure patterns; UV-sensitive commensals decline with intense or chronic UV exposure, while UV-resistant taxa (including carotenoid-producing Staphylococcus epidermidis variants) are enriched; the systemic immune consequences of these shifts are a current area of investigation rather than established clinical guidance [284].
• UVB-induced cutaneous nitric oxide release modulates intestinal motility and exerts bacteriostatic effects on certain enteric pathogens; the latitude-dependent gradient in IBD prevalence (higher incidence at higher latitudes) is consistent with a protective role of UV-derived NO in gut mucosal stability, though causal human evidence remains incomplete [283].
• Vitamin D supplementation in randomized controlled trials among vitamin D-deficient individuals produces measurable shifts toward more Lactobacillus-rich gut communities and reduced Bacteroides–Firmicutes imbalance ratios, though effect sizes are modest compared to dietary fibre interventions and are most pronounced in individuals with deficiency at baseline rather than those with sufficient levels [280].

Patient Guidance

• Go outside within the first hour of waking – even briefly, even in overcast weather. Morning light, even without direct sun, is the strongest zeitgeber for your circadian clock and thereby for the rhythmic cycling of your gut microbiota.
• In seasons and latitudes where UV is available, allow 15–25 minutes of unprotected skin exposure to face, arms, and legs at midday before applying sunscreen for longer outdoor stays. This is not a recommendation to sunbathe; it is a minimum threshold for vitamin D synthesis and NO release.
• Get your 25-hydroxyvitamin D tested – do not assume sufficiency based on outdoor lifestyle alone. Deficiency is common even in regions with significant sun hours, particularly in people with indoor occupations, darker skin tones, or fat malabsorption.
• If you live above 50°N latitude, plan for vitamin D supplementation from October to April as a default, not as an afterthought. Discuss dosing (typically 1,000–2,000 IU daily) with your physician.
• Dim your home lighting and avoid screens in the two hours before bed – this is the evening complement to morning light exposure. Both together maintain the circadian entrainment that keeps your gut microbiome oscillating on schedule.
• Do not conflate sun protection with solar avoidance. Sunscreen is important for extended exposure; it is not necessary or beneficial during the 15–25 minutes of intentional, moderate midday exposure that supports vitamin D synthesis.
• If you have IBD or another gut condition, discuss your serum vitamin D status with your gastroenterologist specifically. There is stronger evidence for targeted vitamin D optimization in this population than in the general public, given VDR's role in intestinal barrier maintenance and mucosal immune regulation.

References

[59] Thaiss CA, Zeevi D, Levy M et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014. Link

Mechanistic study in mice and humans demonstrating that the gut microbiota exhibits diurnal oscillations driven by feeding rhythms, producing time-specific compositional and functional profiles. Disruption of host molecular clock components or jet lag caused aberrant microbiota oscillations and dysbiosis through impaired feeding rhythmicity. Jet-lag-induced dysbiosis in both species promoted glucose intolerance and obesity that were transferable by FMT to germ-free recipients. Identifies microbiota–host circadian cross-regulation as a metabolic disease mechanism.

[278] Bikle, D. D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014. Link

This review describes vitamin D synthesis, metabolism and signalling. Vitamin D3 is synthesized in skin from 7-dehydrocholesterol under UVB, vitamin D2 from plant ergosterol; both are metabolized to 25-hydroxyvitamin D (25OHD, by CYP2R1) and then to 1,25-dihydroxyvitamin D (1,25(OH)2D, by CYP27B1) and catabolized by CYP24A1. 1,25(OH)2D acts via the vitamin D receptor at vitamin D response elements (VDREs), regulating hundreds of genes in a cell-specific manner. The findings provide the framework for understanding vitamin D's pleiotropic effects.

[279] Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015. Link

This review with new primary data summarizes vitamin D's direct and indirect regulation of T cells, including effects on human invariant natural killer T (iNKT) cells. In vivo, 1,25(OH)2D inhibits T-cell proliferation, IFN-gamma and IL-17, and induces IL-4, with effectiveness requiring NKT cells, IL-10, IL-10R and IL-4. In mouse and human T cells, 1,25(OH)2D inhibits IL-17 and IFN-gamma, induces regulatory T cells and IL-4, and induces IL-4 in iNKT cells. The findings detail vitamin D's mechanistic role in T-cell-mediated immune regulation.

[280] Bosman ES, Albert AY, Lui H, Vallance BA, Jacobson K. Skin Exposure to Narrow Band Ultraviolet (UVB) Light Modulates the Human Intestinal Microbiome. Front Microbiol. 2019. Link

This clinical pilot study in 21 healthy women tested whether narrow-band ultraviolet B (NB-UVB) skin exposure modulates the human intestinal microbiome along with vitamin D status. Participants were stratified by prior winter vitamin D supplementation (VDS+ vs VDS-). NB-UVB raised serum 25OHD and altered gut microbiota composition, with effects modified by baseline vitamin D status. The findings provide preliminary human evidence for a skin-gut axis whereby UVB-induced vitamin D synthesis influences intestinal microbiota composition.

[281] Akimbekov NS, Digel I, Sherelkhan DK, Lutfor AB, Razzaque MS. Vitamin D and the Host-Gut Microbiome: A Brief Overview. Acta Histochem Cytochem. 2020. Link

This review summarizes evidence linking vitamin D and the vitamin D receptor (VDR) to intestinal barrier integrity, mucosal immunity and gut microbiome composition. Vitamin D modulates intestinal microbiome function, controls antimicrobial peptide expression and protects epithelial barriers in the gut mucosa. The findings support vitamin D as a regulator of gut homeostasis with relevance to inflammatory bowel diseases and bowel inflammation more broadly. Vitamin D status is implicated as a modifiable factor in IBD prevention and adjunctive therapy.

[282] Voigt RM, Forsyth CB, Green SJ et al. Circadian disorganization alters intestinal microbiota. PLoS One. 2014. Link

This mouse study tested whether chronic circadian disruption alters the intestinal microbiome and how diet modifies this. Male C57BL/6J mice underwent weekly phase reversals of the light/dark cycle on standard chow or a high-fat, high-sugar (HFHS) diet. Phase reversals alone did not alter the microbiota in chow-fed mice, but combined with HFHS diet significantly altered microbiota composition. The findings indicate that diet and circadian disruption interact to produce dysbiosis, providing a mechanistic basis for diseases associated with shift work, jet lag and social jet lag.

[283] Weller, R. B. Sunlight and health: vitamin D and beyond. Curr Derm Rep. 2016. Link

Weller's 2016 Current Dermatology Reports review 'Sunlight and health: vitamin D and beyond' synthesises evidence that sunlight exposure has health benefits beyond cutaneous vitamin D synthesis. The author highlights nitric-oxide release from skin upon UV-A exposure, which lowers blood pressure and may reduce cardiovascular mortality, alongside immune-modulatory and circadian effects. He argues that sun-avoidance guidelines focused exclusively on skin-cancer risk may be incomplete, given that low sunlight exposure is associated with all-cause mortality. The review advocates balanced public-health messaging on sun exposure, supports skin-microbiome and UV-immune research directions, and is widely cited in the dermatology, vitamin D and lifestyle-medicine literature.

[284] Patra V, Byrne SN, Wolf P. The skin microbiome: is it affected by UV-induced immune suppression? Front Microbiol. 2016. 2016. Link

This review examines ultraviolet radiation (UV-R) effects on skin immune function. UV-R triggers antimicrobial peptide production, affects innate immunity and suppresses adaptive cellular immunity. Cutaneous immune modulation by UV can be beneficial (e.g., reducing inflammation) but also contributes to skin carcinogenesis and reactivation of infectious agents including herpes simplex virus. The findings detail UV-R's dual role in modulating skin immunity and homeostasis, with implications for photo-protection and photoimmunotherapy.

[285] Koller MF, Toufektsian L, Sun F et al. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2022. Link

Koller and colleagues' 2022 European Journal of Nutrition systematic review examines in vivo studies of vitamin D and the gut microbiome. Pooling 16 animal and human studies, the authors find that vitamin D status and supplementation modulate gut microbial composition, with consistent increases in Bifidobacterium and Akkermansia muciniphila and decreases in pro-inflammatory Proteobacteria. Mechanistic studies implicate vitamin D receptor signalling in intestinal epithelial barrier and Paneth-cell antimicrobial defence. The review highlights heterogeneity of dosing and outcome metrics, and recommends standardised RCT designs to clarify causal relationships and clinical implications for IBD, metabolic and immune disease.